In addition, lipocalin-2 serum levels were higher in patients suffering from hypertension [98,99] and were reported to possibly decline in type 2 diabetes patients [99,100], indicating a complex interplay between metabolic diseases and serum lipocalin-2 levels. This evidence concerns the gene LCN2 and Other metabolic disease.